Validation of the methotrexate-first strategy in patients with early, poor-prognosis rheumatoid arthritis: Results from a two-year randomized, double-blind trial

James R. O'Dell, Jeffrey R. Curtis, Ted R. Mikuls, Stacey S. Cofield, S. Louis Bridges, Veena K. Ranganath, Larry W. Moreland

Research output: Contribution to journalArticlepeer-review

54 Scopus citations

Fingerprint

Dive into the research topics of 'Validation of the methotrexate-first strategy in patients with early, poor-prognosis rheumatoid arthritis: Results from a two-year randomized, double-blind trial'. Together they form a unique fingerprint.

Medicine & Life Sciences